The CBD market has recently established itself as one of the most robust and promising markets in the country. This growth has directly affected all businesses associated with the industry including Green Roads and our partner EVIO Labs. EVIO Labs has recently expanded their testing capabilities with new scientific instruments in their Florida locations.
EVIO Labs is the independent laboratory responsible for testing the CBD extracts used in Green Roads products. They ensure our pharmacist formulated products comply with all industry standards and safety regulations.
“In addition to analyzing cannabis for beneficial compounds like cannabinoids and terpenes, we ensure safety by analyzing for contaminants such as pesticides, heavy metals, residual solvents, mycotoxins, aflatoxins and pathogens using instruments such as HPLC, GC-MS/MS, LC-MS/MS, and ICP-MS provided by Shimadzu,” said Martinez.
“With the current patient count on the rise, we’ve continued to expand our operation by adding additional Shimadzu equipment to meet the expected volume of samples in the months ahead,” said Chris Martinez, Co-Founder and President of EVIO Labs Florida. “Increasing our capabilities to analyze over 1400+ samples a day ensures that our clients will receive results in an expeditious manner while safeguarding patients will have access to their medicine.”
EVIO Labs is the first ISO Accredited Cannabis Testing laboratory in the state making it a pioneer in the field. In addition to their two Florida facilities, EVIO Labs currently has cannabis testing laboratories in Oregon, California, Colorado, Massachusetts, and in Canada’s Alberta province.
The post CBD Market Watch: Green Roads Partner Lab Expands Its Facilities appeared first on Green Roads.